Evotec investors
WebDescription. Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as … WebApr 10, 2024 · (RTTNews) - Evotec SE (EVO) issued an update on the cyber attack that was detected on 6 April, 2024. The company noticed unusual activity in one of its IT …
Evotec investors
Did you know?
WebJun 15, 2024 · Shares of Evotec lost 3.8% on Tuesday as investors probably jeered the news. The stock has plunged 50.8% so far this year compared with the industry’s decrease of 28.7%. WebINVESTOR'S BUSINESS DAILY 03:00 AM ET 11/29/2024 On Monday, Evotec ( EVO) got an upgrade for its IBD SmartSelect Composite Rating from 92 to 96. Sorry, the video player failed to load. (Error...
WebEvotec places great emphasis on a continuous dialog with financial analysts and investors. Please find below an overview of Evotec's financial calendar as well as upcoming and previous investor relations events. Reset filters Location Event Type Year 27 November2024 German Equity Forum Venue: Frankfurt am Main Organisers: Deutsche Börse WebNov 19, 2024 · Evotec SE today presents the progress made in accelerating its co-owned pipeline and its global infrastructure "The R&D Autobahn to Cures". Dr Werner Lanthaler, Chief Executive Officer of Evotec ...
WebMar 28, 2024 · Within these areas of expertise, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics and has to-date established a portfolio of … WebNov 9, 2024 · In total, Evotec expects the gross proceeds of the transaction to amount to $ 500 million comprising the base offering of 20,000,000 ADSs ($ 435 million) and, upon closing, the exercised Option to purchase 2,995,000 additional ADSs ($ 65 million), before deducting underwriting commissions and estimated offering expenses payable by Evotec.
WebHamburg, Germany, and Greenwich, CT - 30 July 2024: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) and Aptuit announced today that they have entered into a definitive agreement under which Evotec will acquire Aptuit for $ 300 m.
WebSep 18, 2015 · Just - Evotec Biologics General Information. Description. Developer of biotherapeutic technologies intended to dramatically expand global access to biotherapeutics. The company's offerings including integrating highly synergistic scientific expertise and machine learning driven technologies for design, development and … basilan tourismWebApr 10, 2024 · Evotec SE (FFSE:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced an update on the cyber attack that was detected on 06 … tablica i kredaWebDec 1, 2024 · Evotec saw its IBD SmartSelect Composite Rating jump to 96 Wednesday, up from 90 the day before. The new rating shows the stock is outpacing 96% of all stocks when it comes to the most important ... basilar adalahWebThe successful candidate will join Evotec’s BD Team to commercialize Evotec’s assets, technology and create strategic R&D partnerships. This is a remote based position, but … tablica francuske nogometne ligeWebMay 26, 2024 · HAMBURG, GERMANY / ACCESSWIRE / May 26, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced that the Company has participated in the Series C funding... basil antwerpenWebThe Investor Relations department of Evotec SE acts as an interface between the Company and the capital markets. Our extensive investor relations work focuses on an … To underline this, Evotec publicly committed itself to be an attractive and diverse … Climate Protection. Evotec commits itself to climate action and as it is embedded in … The Evotec collection. Evotec’s library contains 450,000 compounds consisting … Evotec Business Development T +44.(0)1235.86 15 61 F +44.(0)1235.86 … Evotec offers services and alliances based on its state-of-the-art technology … In this section you can find Evotec's current "Conditions of Purchase" available for … 1) 2024 restated for IFRS 15 and modified by the effect of the finalisation of Aptuit's … Hamburg, Germany, – Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, … Evotec places great emphasis on a continuous dialog with financial analysts … Eternygen today announced the first closing of its Series A2 funding round led by … tablica informacyjna na stojakuWebDec 23, 2024 · Evotec is not owned by hedge funds. Looking at our data, we can see that the largest shareholder is T. Rowe Price Group, Inc. with 10% of shares outstanding. With 10.0% and 6.5% of the shares... basilar and perihilar atelectasis